Product category:
Microbiology
News Release from: Warnex
Edited by the Laboratorytalk Editorial
Team on 06 February 2008
Warnex's to continue laboratory services
business
Warnex's board of directors has concluded that at the present time, the option which provides the most value for its shareholders is the continued operation of its laboratory services business
Warnex has finalised its review of various strategic options for its ongoing laboratory services business following an announcement made in April 2007 It has ended this review process and has terminated the mandates of the independent committee of the board of directors and GMP Securities
This article was originally published on Laboratorytalk on 21 Mar 2006 at 8.00am (UK)
Related stories
Quantitative PCR test for food testing
Warnex has announced the launch of a quantitative test for Campylobacter for use with the real-time PCR-based Warnex rapid pathogen detection system
Warnex signs up US service lab, AmeriSci Bio-Chem
AmeriSci Bio-Chem, a leading scientific service laboratory based in Midlothian, Virginia, will offer real-time PCR pathogen testing services using the Warnex rapid pathogen detection system
The company will focus on maximising the profitability of its analytical, bioanalytical and medical laboratory divisions, on their continued growth as well as on the refinancing and restructuring of its debt instruments.
"The board of directors believes in the continued success of Warnex's laboratory-based services," said Richard Laferriere, chairman of the board of directors.
"After having undergone a comprehensive analysis of the current options, the board believes that the best avenue to generate value for Warnex's shareholders lies in the continued profitable growth of Warnex's operations".
"2007 has been a year of many changes for Warnex, with the divestiture of our pathogen detection business and our increased focus on the laboratory services sector," said Mark Busgang, president and CEO.
"We are currently negotiating the refinancing of our debt instruments and we have confidence that our balance sheet will be more stable in the near future.
"We are dedicated to offering quality services to our customers and to continue to grow our analytical, bioanalytical and medical laboratories business both organically and through acquisitions.".
• Warnex: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
